• Report Description
  • Request ToC
  • Request Methodology

High content screening is defined as the screening method that is used in drug discovery as well as biological research. It is mostly used to identify various substances such as small molecules, peptides, and others.  It also known as high-content analysis or cellomics. There are various advantages of high content screening as compared to traditional techniques such as More information from cellular samples, more meaningful results, more questions answered simultaneously and others. The main function of high content screening is to not only combine high-throughput automated imaging and but also analysis to extract quantitative multi-parametric data at the single-cell level. Biotechnology, pharmaceutical, research and development and others are some of the major end user industries of High content screening market. Numerous types of software are used in high content screening such as image capture software, image evaluation software, data storage software and others.

Furthermore, increasing usage of high throughput screening and rising demand from drug development & biological research are some of the major factors which affects the growth of market. However, increasing Number of Cros Providing HCS Services and growing demand emerging market are expected to create a new opportunity for market expansion. Although, issue related to lower Adoption of HCS Instruments due to their high prices are expected to restrain the market growth to a certain extent.

High content screening market segmentation:

By End User-

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Academic and Government Institutes

By Application-

  • Primary and Secondary Screening
  • Compound Profiling
  • Target Identification and Validation
  • Toxicity Studies
  • Other Applications

By Product-

  • Instruments {Cell Imaging and Analysis Systems, Flow Cytometers}
  • Consumables {Reagents & Assay Kits, Microplates , Other Consumables}
  • Software
  • Services
  • Accessories

Regional Insight-

The market is divided into five regions namely North America, Asia Pacific, Europe, Middle East & Africa, Latin America. North America is estimated to hold the major share of the global high-content screening market during the forecast period. It is followed by Europe, Asia-Pacific, Latin America, & the Middle East & Africa. In addition, the presence of various pharmaceutical industry and government initiative on research and development expenditure in healthcare sector are expected to fuel the demand for high content screening market in North America region. However, the Asia-Pacific market is expected to register the highest growth during the forecast period, owing to the growing demand from emerging market and rising disposable incomes among middles class families.

Few Key Players in High Content Screening Market-

  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Olympus Corporation
  • PerkinElmer Inc.
  • Merck Millipore Corporation
  • Danaher Corporation (Molecular Devices)
  • Yokogawa Electric Corporation
  • Sysmex Corporation
  • Others.

Recent Development-

  • In December 2019, the Olympus Corporation (Japan) had launched the scanR HCS station. It is a cell imaging solution and uses artificial intelligence to allow next-generation biological research. Hence, this launch will increase the product portfolio of the company.
  • In March 2019, the Digital Biomedical Imaging Systems AG had reported processing as well as analysis of HCS datasets. It is used by custom-developed heuristic algorithms implemented in common open-source image analysis software. This software is used to identify chemical modifiers of glomerular cyst formation. Thus, this initiative will create positive for market growth in future.   

Get a brochure of this research study Click Here

Request For Customization



Request Customization

Check Discount



Request Discount